Dr. Gregory Buford says aesthetic patients want more personalization and long-term planning

Denver plastic surgeon Dr. Gregory Buford is arguing that aesthetic medicine is moving toward individualized treatment plans, balanced outcomes and longer-term thinking as patients ask for more customization and new technologies. He also says artificial intelligence and emerging products like alloClae and Motiva may help, but should stay subordinate to clinical judgment. Why it matters: - Patient demand is pushing aesthetic medicine away from one-size-fits-all procedures and toward treatment plans built around proportion, anatomy and durability. - The shift affects how surgeons counsel patients, choose products and evaluate new technologies in a crowded market. - Dr. Gregory Buford, founder of BEAUTY by BUFORD in Denver, says the most durable results still depend on physician judgment, not trends or algorithms. What happened: - Dr. Buford outlined his views on patient preferences, technology trends and clinical decision-making in aesthetic medicine. - He said many consultations now focus on individual features and realistic enhancement rather than copying celebrity looks. - He also said his practice evaluates technologies such as alloClae and Motiva as they enter the market. - Dr. Buford described artificial intelligence as a useful clinical tool, but not a substitute for in-person evaluation and surgeon experience. The details: - Dr. Buford said social media, patient education platforms and fast-changing consumer preferences are reshaping aesthetic consultations. - He said practitioners need to balance patient requests with established clinical principles. - Dr. Buford said long-term outcomes and individualized care plans require a measured approach, even when popular aesthetics move in a different direction. - He said treatment planning should account for how a procedure affects surrounding anatomy and overall facial or body balance. - Dr. Buford said concerns about “filler fatigue” reflect broader questions about treatment strategy, provider judgment and long-term planning. - He said the same approach applies to breast augmentation, body contouring and facial rejuvenation. - Dr. Buford said his planning process starts with a broad assessment of facial and body proportions before narrowing to specific treatment areas. - He said that approach is meant to support balanced results that remain consistent over time. - He said artificial intelligence tools for facial analysis, education and planning can provide useful information, but should remain supplementary to clinical experience. - Dr. Buford said patients now have more information than ever through online resources and AI platforms, but those tools cannot replace a physician’s exam. - He said newer options in volume restoration may help patients who are not candidates for traditional fat grafting. - Dr. Buford said alloClae and the forthcoming dermoClae platform may offer a more versatile and potentially durable option for volume deficiencies. - He said products must show clinical value and acceptable safety before being added to treatment protocols. - Dr. Buford said interest in Motiva breast implants reflects broader attention to design characteristics and how the device compares with existing implant options. - He said additional competition among implant makers could drive improvements in design, safety and performance. Between the lines: - Dr. Buford is framing aesthetic care as a discipline where restraint can matter as much as innovation. - His comments suggest that emerging technology may win adoption only if it supports a physician-led philosophy centered on proportion and long-term results. - The message also reflects a broader industry tension: patients want faster access to new tools, while surgeons still have to decide what is truly clinically useful. What’s next: - Dr. Buford said he will continue evaluating new products and monitoring long-term data as it becomes available. - He said patients will likely keep driving demand for more customized plans and more transparent communication. - BEAUTY by BUFORD says it will continue emphasizing individualized treatment planning, long-term outcomes and comprehensive aesthetic care. The bottom line: - Dr. Buford’s core argument is simple: in aesthetic medicine, technology can help, but judgment, anatomy and balance still determine the result.